Bystander effect on brain tissue of mesoangioblasts producing neurotrophins

Cell Transplantation

Volumn 21, Issue 8, 2012, Pages 1613-1627

  Su, Tao ^a,b   Scardigli, Raffaella ^c,d   Fasulo, Luisa ^d   Paradiso, Beatrice ^a,b   Barbieri, Mario ^a,b   Binaschi, Anna ^a,b   Bovolenta, Roberta ^a,b   Zucchini, Silvia ^a,b,e   Cossu, Giulio ^f   Cattaneo, Antonino ^e,g   Simonato, Michele ^a,b,e  

^a UNIVERSITY OF FERRARA   (Italy)

^b National Institute of Neuroscience   (Italy)

^c INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

^d EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^e Laboratorio per le Tecnologie delle Terapie Avanzate   (Italy)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g SCUOLA NORMALE SUPERIORE   (Italy)

Author keywords

Mesoangioblast; Neurodegeneration; Neurotrophin; Stem cells

Indexed keywords

ADHESIN; BRAIN DERIVED NEUROTROPHIC FACTOR; IMMUNOGLOBULIN G; K 252A; NERVE GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; BRAIN TISSUE; BYSTANDER EFFECT; CELL DIFFERENTIATION; CELL MIGRATION; CELL SELECTION; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; HIPPOCAMPUS; MESOANGIOBLAST; MESODERM; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

ANIMALS; APOPTOSIS; BRAIN-DERIVED NEUROTROPHIC FACTOR; BYSTANDER EFFECT; CARBAZOLES; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; HIPPOCAMPUS; IMMUNOGLOBULIN G; INDOLE ALKALOIDS; MESODERM; NERVE GROWTH FACTOR; NEURONS; PC12 CELLS; RATS; RECEPTOR, TRKB; RECOMBINANT PROTEINS;

EID: 84868104535     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X640475     Document Type: Article

References (67)

1. Bartus, R. T.; Dean, 3rd, R. L.; Beer, B.; Lippa, A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science 217(4558):408-414; 1982.
2. Boado, R. J. A new generation of neurobiological drugs engineered to overcome the challenges of brain drug delivery. Drug News Perspect. 21(9):489-503; 2008.
3. Capsoni, S.; Giannotta, S.; Cattaneo, A. Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice. Proc. Natl. Acad. Sci. USA 99(19):12432-12437; 2002.
4. Capsoni, S.; Ugolini, G.; Comparini, A.; Ruberti, F.; Berardi, N.; Cattaneo, A. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc. Natl. Acad. Sci. USA 97(12):6826-6831; 2000.
5. Cattaneo, A.; Capsoni, S.; Paoletti, F. Towards non invasive nerve growth factor therapies for Alzheimer's disease. J. Alzheimers Dis. 15(2):255-283; 2008.
6. Cheng, B.; Mattson, M. P. NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults. Brain Res. 640(1-2):56-67; 1994.
7. Connor, B.; Young, D.; Yan, Q.; Faull, R. L.; Synek, B.; Dragunow, M. Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res. Mol. Brain Res. 49(1-2): 71-81; 1997.
8. Covaceuszach, S.; Cassetta, A.; Konarev, P. V.; Gonfloni, S.; Rudolph, R.; Svergun, D. I.; Lamba, D.; Cattaneo, A. Dissecting NGF interactions with TrkA and p75 receptors by structural and functional studies of an anti-NGF neutralizing antibody. J. Mol. Biol. 381(4):881-896; 2008.
9. Danielyan, L.; Schafer, R.; von Ameln-Mayerhofer, A.; Buadze, M.; Geisler, J.; Klopfer, T.; Burkhardt, U.; Proksch, B.; Verleysdonk, S.; Ayturan, M.; Buniatian, G. H.; Gleiter, C. H.; Frey, 2nd., W. H. Intranasal delivery of cells to the brain. Eur. J. Cell Biol. 88(6):315-324; 2009.
10. De Rosa, R.; Garcia, A. A.; Braschi, C.; Capsoni, S.; Maffei, L.; Berardi, N.; Cattaneo, A. Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc. Natl. Acad. Sci. USA 102(10):3811-3816; 2005.
11. De Santi, L.; Annunziata, P.; Sessa, E.; Bramanti, P. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Neurol. Sci. 287(1-2):17-26; 2009.
12. Ferguson, I. A.; Schweitzer, J. B.; Bartlett, P. F.; Johnson Jr., E. M. Receptor-mediated retrograde transport in CNS neurons after intraventricular administration of NGF and growth factors. J. Comp. Neurol. 313(4):680-692; 1991.
13. Ferrer, I.; Marin, C.; Rey, M. J.; Ribalta, T.; Goutan, E.; Blanco, R.; Tolosa, E.; Marti, E. BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J. Neuropathol. Exp. Neurol. 58(7):729-739; 1999.
14. Gahwiler, B. H.; Capogna, M.; Debanne, D.; McKinney, R. A.; Thompson, S. M. Organotypic slice cultures: A technique has come of age. Trends Neurosci. 20(10):471-477; 1997.
15. Galli, D.; Innocenzi, A.; Staszewsky, L.; Zanetta, L.; Sampaolesi, M.; Bai, A.; Martinoli, E.; Carlo, E.; Balconi, G.; Fiordaliso, F.; Chimenti, S.; Cusella, G.; Dejana, E.; Cossu, G.; Latini, R. Mesoangioblasts, vessel-associated multipotent stem cells, repair the infarcted heart by multiple cellular mechanisms: A comparison with bone marrow progenitors, fibroblasts, and endothelial cells. Arterioscler. Thromb. Vasc. Biol. 25(4):692-697; 2005.
16. Galvez, B. G.; Sampaolesi, M.; Brunelli, S.; Covarello, D.; Gavina, M.; Rossi, B.; Constantin, G.; Torrente, Y.; Cossu, G. Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. J. Cell Biol. 174(2):231-243; 2006.
17. Gnahn, H.; Hefti, F.; Heumann, R.; Schwab, M. E.; Thoenen, H. NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: Evidence for a physiological role of NGF in the brain? Brain Res. 285(1):45-52; 1983.
18. Gratacos, E.; Perez-Navarro, E.; Tolosa, E.; Arenas, E.; Alberch, J. Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members. J. Neurochem. 78(6):1287-1296; 2001.
19. Greene, L. A.; Tischler, A. S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73(7):2424-2428; 1976.
20. Harper, M. M.; Adamson, L.; Blits, B.; Bunge, M. B.; Grozdanic, S. D.; Sakaguchi, D. S. Brain-derived neurotrophic factor released from engineered mesenchymal stem cells attenuates glutamate- and hydrogen peroxide-mediated death of staurosporine-differentiated RGC-5 cells. Exp. Eye Res. 89(4):538-548; 2009.
21. Hefti, F.; Hartikka, J.; Salvatierra, A.; Weiner, W. J.; Mash, D. C. Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrain. Neurosci. Lett. 69(1):37-41; 1986.
22. Holtzman, D. M.; Li, Y.; Parada, L. F.; Kinsman, S.; Chen, C. K.; Valletta, J. S.; Zhou, J.; Long, J. B.; Mobley, W. C. p140trk mRNA marks NGF-responsive forebrain neurons: Evidence that trk gene expression is induced by NGF. Neuron 9(3):465-478; 1992.
23. Huang, E. J.; Reichardt, L. F. Neurotrophins: Roles in neuronal development and function. Annu. Rev. Neurosci. 24:677-736; 2001.
24. Huber, K. M.; Sawtell, N. B.; Bear, M. F. Brain-derived neurotrophic factor alters the synaptic modification threshold in visual cortex. Neuropharmacology 37(4-5):571-579; 1998.
25. Jiang, B.; Akaneya, Y.; Ohshima, M.; Ichisaka, S.; Hata, Y.; Tsumoto, T. Brain-derived neurotrophic factor induces long-lasting potentiation of synaptic transmission in visual cortex in vivo in young rats, but not in the adult. Eur. J. Neurosci. 14(8):1219-1228; 2001.
26. Kameda, M.; Shingo, T.; Takahashi, K.; Muraoka, K.; Kurozumi, K.; Yasuhara, T.; Maruo, T.; Tsuboi, T.; Uozumi, T.; Matsui, T.; Miyoshi, Y.; Hamada, H.; Date, I. Adult neural stem and progenitor cells modified to secrete GDNF can protect, migrate and integrate after intracerebral transplantation in rats with transient forebrain ischemia. Eur. J. Neurosci. 26(6):1462-1478; 2007.
27. Kano, T.; Abe, T.; Tomita, H.; Sakata, T.; Ishiguro, S.; Tamai, M. Protective effect against ischemia and light damage of iris pigment epithelial cells transfected with the BDNF gene. Invest. Ophthalmol. Vis. Sci. 43(12):3744-3753; 2002.
28. Kristensen, B. W.; Noraberg, J.; Zimmer, J. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures. Brain Res. 917(1):21-44; 2001.
29. Kromer, L. F. Nerve growth factor treatment after brain injury prevents neuronal death. Science 235(4785):214-216; 1987.
30. Labelle, C.; Leclerc, N. Exogenous BDNF, NT-3 and NT-4 differentially regulate neurite outgrowth in cultured hippocampal neurons. Brain Res. Dev. Brain Res. 123(1):1-11; 2000.
31. Larmet, Y.; Reibel, S.; Carnahan, J.; Nawa, H.; Marescaux, C.; Depaulis, A. Protective effects of brain-derived neurotrophic factor on the development of hippocampal kindling in the rat. Neuroreport 6(14):1937-1941; 1995.
32. Larsson, E.; Nanobashvili, A.; Kokaia, Z.; Lindvall, O. Evidence for neuroprotective effects of endogenous brainderived neurotrophic factor after global forebrain ischemia in rats. J. Cereb. Blood Flow Metab. 19(11):1220-1228; 1999.
33. Lauterborn, J. C.; Rex, C. S.; Kramar, E.; Chen, L. Y.; Pandyarajan, V.; Lynch, G.; Gall, C. M. Brain-derived neurotrophic factor rescues synaptic plasticity in a mouse model of fragile X syndrome. J. Neurosci. 27(40):10685-10694; 2007.
34. Li, H.; Qiu, W.; Wang, F.; Wei, F.; Chen, X.; Wu, X.; Huang, Q. Construction and expression of recombinant adenoassociated virus expressing brain-derived neurotrophic factor. Sheng Wu Gong Cheng Xue Bao 24(2):328-332; 2008.
35. Li, Y. X.; Zhang, Y.; Lester, H. A.; Schuman, E. M.; Davidson, N. Enhancement of neurotransmitter release induced by brain-derived neurotrophic factor in cultured hippocampal neurons. J. Neurosci. 18(24):10231-10240; 1998.
36. Lim, J. Y.; Park, S. I.; Kim, S. M.; Jun, J. A.; Oh, J. H.; Ryu, C. H.; Jeong, C. H.; Park, S. H.; Park, S. A.; Oh, W.; Chang, J. W.; Jeun, S. S. Neural differentiation of brainderived neurotrophic factor-expressing human umbilical cord blood-derived mesenchymal stem cells in culture via TrkB-mediated ERK and beta-catenin phosphorylation and following transplantation into the developing brain. Cell Transplant. 20(11/12):1855-1866; 2011.
37. Lindholm, D.; Carroll, P.; Tzimagiogis, G.; Thoenen, H. Autocrine-paracrine regulation of hippocampal neuron survival by IGF-1 and the neurotrophins BDNF, NT-3 and NT-4. Eur. J. Neurosci. 8(7):1452-1460; 1996.
38. Lowenstein, D. H.; Arsenault, L. The effects of growth factors on the survival and differentiation of cultured dentate gyrus neurons. J. Neurosci. 16(5):1759-1769; 1996.
39. Lu, P.; Jones, L. L.; Snyder, E. Y.; Tuszynski, M. H. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp. Neurol. 181(2):115-129; 2003.
40. Makar, T. K.; Bever, C. T.; Singh, I. S.; Royal, W.; Sahu, S. N.; Sura, T. P.; Sultana, S.; Sura, K. T.; Patel, N.; Dhib-Jalbut, S.; Trisler, D. Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle. J. Neuroimmunol. 210(1-2):40-51; 2009.
41. Mandel, R. J. CERE-110, an adeno-associated virus-based gene delivery vector expressing human nerve growth factor for the treatment of Alzheimer's disease. Curr. Opinion Mol. Ther. 12(2):240-247; 2010.
42. Martinez-Serrano, A.; Bjorklund, A. Immortalized neural progenitor cells for CNS gene transfer and repair. Trends Neurosci. 20(11):530-538; 1997.
43. Matsumoto, K.; Yamamoto, K.; Karasawa, Y.; Hino, N.; Nakamura, A.; Takahashi, M.; Araki, H.; Okuyama, S.; Choshi, T.; Sugino, E.; Hibino, S.; Yoshimoto, M. Possible involvement of induction of brain-derived neurotrophic factor in the neuroprotective effect of a 5-phenylpyrimidine derivative. Biochem. Pharmacol. 66(6):1019-1023; 2003.
44. Mesquita, R. M.; Pereira, P. A.; Andrade, J. P. Low levels of brain-derived neurotrophic factor and tyrosine kinase receptor B are related to loss of dentate granule cells after prolonged low-protein feeding in the rat. Neurosci. Lett. 330(2):155-158; 2002.
45. Minasi, M. G.; Riminucci, M.; De Angelis, L.; Borello, U.; Berarducci, B.; Innocenzi, A.; Caprioli, A.; Sirabella, D.; Baiocchi, M.; De Maria, R.; Boratto, R.; Jaffredo, T.; Broccoli, V.; Bianco, P.; Cossu, G. The meso-angioblast: A multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 129(11):2773-2783; 2002.
46. Mobley, W. C.; Rutkowski, J. L.; Tennekoon, G. I.; Gemski, J.; Buchanan, K.; Johnston, M. V. Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons. Brain Res. 387(1):53-62; 1986.
47. Morosetti, R.; Gidaro, T.; Broccolini, A.; Gliubizzi, C.; Sancricca, C.; Tonali, P. A.; Ricci, E.; Mirabella, M. Mesoangioblasts from facioscapulohumeral muscular dystrophy display in vivo a variable myogenic ability predictable by their in vitro behavior. Cell Transplant. 20(8):1299-1313; 2011.
48. Nakagami, Y.; Saito, H.; Matsuki, N. Basic fibroblast growth factor and brain-derived neurotrophic factor promote survival and neuronal circuit formation in organotypic hippocampal culture. Jpn. J. Pharmacol. 75(4):319-326; 1997.
49. Paradiso, B.; Marconi, P.; Zucchini, S.; Berto, E.; Binaschi, A.; Bozac, A.; Buzzi, A.; Mazzuferi, M.; Magri, E.; Navarro Mora, G.; Rodi, D.; Su, T.; Volpi, I.; Zanetti, L.; Marzola, A.; Manservigi, R.; Fabene, P. F.; Simonato, M. Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model. Proc. Natl. Acad. Sci. USA 106(17):7191-7196; 2009.
50. Persic, L.; Roberts, A.; Wilton, J.; Cattaneo, A.; Bradbury, A.; Hoogenboom, H. R. An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries. Gene 187(1):9-18; 1997.
51. Righi, M.; Tongiorgi, E.; Cattaneo, A. Brain-derived neurotrophic factor (BDNF) induces dendritic targeting of BDNF and tyrosine kinase B mRNAs in hippocampal neurons through a phosphatidylinositol-3 kinase-dependent pathway. J. Neurosci. 20(9):3165-3174; 2000.
52. Rizvanov, A. A.; Kiyasov, A. P.; Gaziziov, I. M.; Yilmaz, T. S.; Kaligin, M. S.; Andreeva, D. I.; Shafigullina, A. K.; Guseva, D. S.; Kiselev, S. L.; Matin, K.; Palotas, A.; Islamov, R. R. Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis-a novel approach in stem cell therapy. Neurochem. Int. 53(6-8):389-394; 2008.
53. Sampaolesi, M.; Blot, S.; D'Antona, G.; Granger, N.; Tonlorenzi, R.; Innocenzi, A.; Mognol, P.; Thibaud, J. L.; Galvez, B. G.; Barthelemy, I.; Perani, L.; Mantero, S.; Guttinger, M.; Pansarasa, O.; Rinaldi, C.; Cusella De Angelis, M. G.; Torrente, Y.; Bordignon, C.; Bottinelli, R.; Cossu, G. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444(7119):574-579; 2006.
54. Sasaki, M.; Radtke, C.; Tan, A. M.; Zhao, P.; Hamada, H.; Houkin, K.; Honmou, O.; Kocsis, J. D. BDNFhypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J. Neurosci. 29(47):14932-14941; 2009.
55. Seiler, M.; Schwab, M. E. Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res. 300(1):33-39; 1984.
56. Simonato, M.; Tongiorgi, E.; Kokaia, M. Angels and demons: Neurotrophic factors and epilepsy. Trends Pharmacol. Sci. 27(12):631-638; 2006.
57. Stoppini, L.; Buchs, P. A.; Muller, D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37(2):173-182; 1991.
58. Tagliafico, E.; Brunelli, S.; Bergamaschi, A.; De Angelis, L.; Scardigli, R.; Galli, D.; Battini, R.; Bianco, P.; Ferrari, S.; Cossu, G.; Ferrari, S. TGFbeta/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts. J. Cell Sci. 117(Pt 19):4377-4388; 2004.
59. Tedesco, F. S.; Dellavalle, A.; Diaz-Manera, J.; Messina, G.; Cossu, G. Repairing skeletal muscle: Regenerative potential of skeletal muscle stem cells. J. Clin. Invest. 120(1):11-19; 2010.
60. Thoenen, H.; Sendtner, M. Neurotrophins: From enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat. Neurosci. 5 Suppl:1046-1050; 2002.
61. Tuszynski, M. H. Nerve growth factor gene therapy in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 21(2):179-189; 2007.
62. Tuszynski, M. H.; Thal, L.; Pay, M.; Salmon, D. P. U. H. S.; Bakay, R.; Patel, P.; Blesch, A.; Vahlsing, H. L.; Ho, G.; Tong, G.; Potkin, S. G.; Fallon, J.; Hansen, L.; Mufson, E. J.; Kordower, J. H.; Gall, C.; Conner, J. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat. Med. 11(5):551-555; 2005.
63. Tuszynski, M. H. U. H. S.; Amaral, D. G.; Gage, F. H. Nerve growth factor infusion in the primate brain reduces lesioninduced cholinergic neuronal degeneration. J. Neurosci. 10(11):3604-3614; 1990.
64. Wilhelmi, E.; Schoder, U. H.; Benabdallah, A.; Sieg, F.; Breder, J.; Reymann, K. G. Organotypic brain-slice cultures from adult rats: Approaches for a prolonged culture time. Altern. Lab. Anim. 30(3):275-283; 2002.
65. Williams, L. R.; Varon, S.; Peterson, G. M.; Wictorin, K.; Fischer, W.; Bjorklund, A.; Gage, F. H. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc. Natl. Acad. Sci. USA 83(23):9231-9235; 1986.
66. Xiang, Z.; Hrabetova, S.; Moskowitz, S. I.; Casaccia- Bonnefil, P.; Young, S. R.; Nimmrich, V. C.; Tiedge, H.; Einheber, S.; Karnup, S.; Bianchi, R.; Bergold, P. J. Longterm maintenance of mature hippocampal slices in vitro. J. Neurosci. Methods 98(2):145-154; 2000.
67. Zuccato, C.; Cattaneo, E. Role of brain-derived neurotrophic factor in Huntington's disease. Prog. Neurobiol. 81(5-6):294-330; 2007.